Sagent Pharmaceuticals to Present at Two Upcoming Financial Conferences
SCHAUMBURG, Ill., Oct. 26 Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company with a focus on injectable products, today announced that Jeffery M. Yordon, chief executive officer, founder and chairman of the board of Sagent Pharmaceuticals, has accepted invitations to present at upcoming conferences sponsored by Oppenheimer & Co. Inc. and Lazard Capital Markets LLC.
On Tuesday, November 3, 2009, Mr. Yordon will present at the Oppenheimer 20th Annual Healthcare Conference at 11:25am Eastern Time. This conference, which is taking place November 3-4 at the Waldorf=Astoria Hotel in New York, NY, will feature presentations by leading public and private companies in the pharmaceutical, biotechnology, medical device, healthcare facility, health technology and distribution, provider and service industries.
Two weeks following, Mr. Yordon will present at the Lazard Capital Markets 6th Annual Healthcare Conference at 10:55am Eastern Time on Tuesday, November 17, 2009. This conference, which is being held November 17-18 at the St. Regis Hotel in New York, NY, will feature presentations from 150 leading healthcare companies, five expert panel discussions, a "Conference Top Picks" panel with Lazard Capital Markets research analysts, and Senator Tom Daschle as the keynote speaker, on "Solving the Healthcare Crisis."
About Sagent Pharmaceuticals, Inc.
Sagent Pharmaceuticals, founded in 2006, is a privately held specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products, with a specific emphasis on injectable products. Sagent has created a unique, global network of resources, comprised of rapid development capabilities, sophisticated manufacturing and innovative drug-delivery technologies, quickly yielding an extensive portfolio of pharmaceutical products that fulfills the evolving needs of patients. Sagent currently has more than 200 products in development.
To Discover Injectables Excellence(TM) and learn more about Sagent, please visit www.SagentPharma.com.
SOURCE Sagent Pharmaceuticals, Inc.
You May Also Like